Despite the enormous challenges presented by nature, trials that fail time and time again, or a disease that appears to resist all efforts, the persistence and winning spirit of Boehringer Ingelheim Vetmedica, Inc.,’s employees and teams make it possible to come up with products and solutions to improve the health of animals and, ultimately, the health and well-being of mankind.

Research is only possible if a group of highly-qualified and dedicated researchers cooperate in the search for solutions to medical needs. We are proud of the contributions of our research and development team members to the animal health industry.

Scientific publications by some of our R&D scientists in the last 5 years

  • 2014

    • Cline G, TJ Kaiser, KT Claxton, DM Jordan, WL Bryson. Efficacy of a Salmonella Typhimurium and Salmonella Choleraesuis combination vaccine against S. Typhimurium challenge in growing pigs. Allan Leman Conference, Minneapolis, September 2014
    • Kaiser TJ, KT Claxton, DM Jordan, G Cline, K Saddoris-Clemons, WL Bryson. Salmonella Choleraesuis-Typhimurium attenuated live culture vaccine efficacy evaluation in two-week-old pigs with S. Choleraesuis. Allan Leman Conference, Minneapolis, September 2014
    • Smiley R, TJ Kaiser, DM Jordan, G Cline, K Saddoris-Clemons, B Fergen, J Husa. Two week onset of immunity Evaluation of Salmonella Choleraesuis-Typhimurium attenuated live culture vaccine efficacy evaluation in two-week-old. Allan Leman Conference, Minneapolis, September 2014
    • Kaiser TJ, KT Claxton, DM Jordan, K Saddoris-Clemons, G Cline. Efficacy of a Salmonella Typhimurium and Salmonella Choleraesuis experimental combination vaccine against S. Typhimurium and S. Choleraesuis challenges in growing pigs. American Association for Swine Practitioners Convention Proceedings. 2014
    • Willbold E, Gu X, Albert D, Kalla K, Bobe K, Brauneis M, Janning C, Nellesen J, Czayka W, Tillmann W, Zheng Y, Witte F. Effect of the addition of low rare earth elements (lanthanum, neodymium, cerium) on the biodegradation and biocompatibility of magnesium. Acta Biomater. 2014 Sep 30. pii: S1742-7061(14)00432-2
  • 2013

    • Zimmerman, A.D., A.L. Klein, R.E. Buterbaugh, B. Hartman, C.L. Rinehart, and C.C.L. Chase. Vaccination with a multivalent modified-live virus vaccine administered one year prior to challenge with bovine viral diarrhea virus type 1b and 2a in pregnant heifers. The Bov Pract 2013;47(1):22-33.
    • Zimmerman, A.D., A.L. Klein, R.E. Buterbaugh, C.L. Rinehart, and C.C.L. Chase. Protection against bovine herpesvirus type 1 (BHV-1) abortion following challenge 8 months or approximately 1 year after vaccination. The Bov Pract 2013;47(2):73-81.
    • Hoenig M, Traas AM, Schaeffer DJ. Evaluation of routine hematology profile results and fructosamine, thyroxine, insulin, and proinsulin concentrations in lean, overweight, obese, and diabetic cats. J Am Vet Med Assoc. 2013 Nov 1;243(9):1302-9.
    • Jordan DM, T Kaiser, G Cline. Efficacy of a Salmonella Typhimurium and Salmonella Choleraesuis experimental combination vaccine against S. Typhimurium challenge in growing pigs. Safe Pork. 2013
  • 2012

    • Rinehart, C.L., A.D. Zimmerman, R.E. Buterbaugh, R.A. Jolie, and C.C.L. Chase. Efficacy of vaccination of cattle with the Leptospira interrogans serovar hardjo type hardjoprajitno component of a pentavalent Leptospira bacterin against experimental challenge with Leptospira borgpetersenii serovar hardjo type hardjo-bovis. Am J Vet Res 2012;73(5):735-740.
    • Coetzee JF, Mosher RA, Kukanich B, Gehring R, Robert B, Reinbold JB, and White BJ. Pharmacokinetics and effect of intravenous meloxicam in weaned Holstein calves following scoop dehorning without local anesthesia. BMC Veterinary Research 2012; 8:153.
  • 2011

    • Barron S, Coetee JF, Dritz SS, Reinbold JB, Gehring R, Kukanich B. Pharmacokinetics and physiologic effects of xylazine-ketamine-butorphanol administered intramuscularly alone or in combination with orally administered sodium salicylate on biomarkers of pain in Holstein calves following concurrent castration and dehorning. Am J Vet Res. 2011; 72(10):1305–1317.
    • Ponder KP, O'Malley TM, Wang P, O'Donnell PA, Traas AM, Knox VW, Aguirre GA, Ellinwood NM, Metcalf JA, Wang B, Parkinson-Lawrence EJ, Sleeper MM, Brooks DA, Hopwood JJ, Haskins ME. Neonatal Gene Therapy with a Gamma Retroviral Vector in Mucopolysaccharidosis VI Cats. Submitted for Publication: Molecular therapy 2011.
    • Kariyawasam, S., Strait, E., Jordan, D. and Kroll, J. Development of a real-time polymerase chain reaction assay for detection of Actinobacillus suis in porcine lung, J Vet Diagn Invest, Vol. 23, Number 5, September 2011.
    • Kariyawasam, S., Strait, E., Jordan, DM. and Kroll, J. Development of a real-time polymerase chain reaction assay for detection of Actinobacillus suis in porcine lung, J Vet Diagn Invest, Vol. 23, Number 5, September 2011.
  • 2010

    • Reinbold JB, Coetzee JF, Sirigireddy KR, Ganta RR. Detection of Anaplasmamarginale and A. phagocytophilum in bovine peripheral blood samples by duplex real-time reverse transcriptase PCR assay. J Clin Micro 2010; 48(7):2424-2432.
    • Reinbold JB, Coetzee JF, Hollis LC, et al. The efficacy of three chlortetracycline regimens in the treatment of persistent Anaplasma marginale infection. Vet Microbiol 2010; 145(1-2):69–75.
    • Traas AM. Clinical trial design and execution in small animals. Clinical Theriogenology 2010:2:208-214
    • Traas AM, Fleck T, Ellings A, Mahbir S, Brown D, Stuebner K, Durso D, DiGregorio M, Bode L, Kievit K, McCall R. Comparison of Ease of Administration of Three Oral Formulations in the Cat. Am J Vet Res. 2010 Jun;71(6):610-4.
    • Janning, C., E. Willbold, C. Vogt, J. Nellesen, A. Meyer-Lindenberg, H. Windhagen, F. Thorey, and F. Witte. "Magnesium Hydroxide Temporarily Enhancing Osteoblast Activity and Decreasing the Osteoclast Number in Peri-implant Bone Remodelling." Acta Biomaterialia, 2010, 1861-868.
  • 2009

    • Zimmerman, A.D., R.E. Buterbaugh, J.A. Schnackel, and C.C.L. Chase. Efficacy of a modified-live virus vaccine administered to calves with maternal antibodies and challenged seven months later with a virulent bovine viral diarrhea type 2 virus. The Bov Pract 2009;43(1):35-43.
    • Reinbold JB, Coetzee JF, Gehring R, et al. Plasma pharmacokinetics of oral chlortetracycline in group fed, ruminating, Holstein steers in a feedlot setting. J Vet Pharm Ther 2009; 33:76–83.
    • Jordan DM, S Layton, R Philips, M Genzow. Modified live PRRS vaccination provides heterologous protection against virulent 1-18-2 challenge Allan Leman Conference, Minneapolis, September 2009